admin

There is a lot of reason to be bullish on Novavax (NASDAQ:NVAX) stock. No, the company’s Covid-19 vaccine has not been granted FDA approval. But that truth in combination with delta variant concerns and international sales prospects make Novavax powerful.  Source: Ascannio/Shutterstock.com Novavax burst onto the scene in a major way back in the summer
0 Comments
Investors have been bullish for at least three years. Much of the credit goes to the Federal Reserve. As it is, Wall Street has a habit of overshooting in both directions. So it is not a surprise to see markets break records about breaking records. Today we will illustrate that over-reaction point with Uber (NYSE:UBER) stock.
0 Comments
ViacomCBS (NASDAQ:VIAC) should be a wildly profitable investment. It isn’t one. The best trade on this stock over the last year was a short. If you borrowed shares to sell during its January and February run-up, you prospered after Archegos Capital collapsed. Source: Jer123 / Shutterstock.com Viacom shares started August 2 near the level they
0 Comments